Literature DB >> 22543949

[New advances in atopic dermatitis].

N Novak1, T Bieber.   

Abstract

Atopic Dermatitis (AD) is one of the most frequent chronic skin diseases. AD is characterized by a complex, heterogeneous pathogenesis. In this review, we highlight some selected aspects of the pathophysiology of AD, which have gained much attention during recent years. These aspects profoundly changed our view of the pathogenesis of AD and will have impact on its management.

Entities:  

Mesh：

Year:  2012        PMID： 22543949     DOI： 10.1007/s00105-011-2298-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  30 in total

1.  The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis.

Authors:  A Heratizadeh; I Mittermann; H Balaji; K Wichmann; M Niebuhr; R Valenta; T Werfel
Journal:  Br J Dermatol       Date:  2011-02       Impact factor: 9.302

2.  Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge.

Authors:  Rui He; Michiko K Oyoshi; Haoli Jin; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-24       Impact factor: 11.205

Review 3.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

4.  Atopic dermatitis.

Authors:  Thomas Bieber
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

5.  Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.

Authors:  Pei-Song Gao; Nicholas M Rafaels; Deguang Mu; Tracey Hand; Tanda Murray; Mark Boguniewicz; Tissa Hata; Lynda Schneider; Jon M Hanifin; Richard L Gallo; Li Gao; Terri H Beaty; Lisa A Beck; Donald Y M Leung; Kathleen C Barnes
Journal:  J Allergy Clin Immunol       Date:  2010-05-13       Impact factor: 10.793

6.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

7.  Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study.

Authors:  C M de Jongh; L Khrenova; M M Verberk; F Calkoen; F J H van Dijk; H Voss; S M John; S Kezic
Journal:  Br J Dermatol       Date:  2008-07-10       Impact factor: 9.302

8.  Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy.

Authors:  Sara J Brown; Yuka Asai; Heather J Cordell; Linda E Campbell; Yiwei Zhao; Haihui Liao; Kate Northstone; John Henderson; Reza Alizadehfar; Moshe Ben-Shoshan; Kenneth Morgan; Graham Roberts; Laury J N Masthoff; Suzanne G M A Pasmans; Peter C van den Akker; Cisca Wijmenga; Jonathan O'B Hourihane; Colin N A Palmer; Gideon Lack; Ann Clarke; Peter R Hull; Alan D Irvine; W H Irwin McLean
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

9.  A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.

Authors:  Padraic G Fallon; Takashi Sasaki; Aileen Sandilands; Linda E Campbell; Sean P Saunders; Niamh E Mangan; John J Callanan; Hiroshi Kawasaki; Aiko Shiohama; Akiharu Kubo; John P Sundberg; Richard B Presland; Philip Fleckman; Nobuyoshi Shimizu; Jun Kudoh; Alan D Irvine; Masayuki Amagai; W H Irwin McLean
Journal:  Nat Genet       Date:  2009-04-06       Impact factor: 38.330

10.  Cytokine modulation of atopic dermatitis filaggrin skin expression.

Authors:  Michael D Howell; Byung Eui Kim; Peisong Gao; Audrey V Grant; Mark Boguniewicz; Anna Debenedetto; Lynda Schneider; Lisa A Beck; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2007-05-23       Impact factor: 10.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.